Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Lilly’s Obesity Drug Strength Fuels Record Rally, Wall Street Optimism

Summary by WTVB
Oct 29 (Reuters) - Eli Lilly shares surged to a record high on Thursday, as sales of blockbuster weight-loss injections helped the drugmaker beat quarterly profit expectations and raise its full-year revenue forecast, ​reinforcing its lead in the boomi...

9 Articles

MarketWatchMarketWatch
Center

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock closed at a record high.

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

·New York, United States
Read Full Article
The Motley FoolThe Motley Fool
Lean Left

Eli Lilly (LLY) Q3 2026 Earnings Call Transcript

Revenue surged 39% on blockbuster obesity drug demand and strong international growth.

·Alexandria, United States
Read Full Article
New York PostNew York Post
Lean Right

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.

·New York, United States
Read Full Article
ReutersReuters
Reposted by
WTVBWTVB
Center

Lilly's obesity drug strength fuels record rally, Wall Street optimism

·London, United Kingdom
Read Full Article
Seeking AlphaSeeking Alpha
Lean Right

Eli Lilly: Mounjaro And Zepbound Keep The Growth Story Alive (NYSE:LLY)

Eli Lilly and Company remains a Buy, as its Q3 results show strong revenue growth and rising Mounjaro and Zepbound sales. Click for a detailed LLY update.

·Ra'anana, Israel
Read Full Article
Folha de S.PauloFolha de S.Paulo

Eli Lilly Makes $6.4 Billion in the Third Quarter - 29/10/2026

The profit of Eli Lilly, producer of the Mounjaro, fired in the third trimester, driven by the strong demand for his treatments for weight loss. The result led the American pharmacist to raise for the second time in three months his revenue projection and made his actions reach a record. Read more (10/29/2026

·São Paulo, Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Forbes España broke the news on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Eli Lilly icon

Eli Lilly

Wall Street icon

Wall Street

Stock Markets icon

Stock Markets

Business icon

Business

Indianapolis icon

Indianapolis

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal